Expansion of current PPD facility in Athlone aimed at meeting growing demand in Europe.
Up to 180 new jobs are to be created in Athlone by US company PPD Inc which is increasing the size of its current facility and adding cell and gene therapy testing to the operation’s portfolio of services.
PPD in Athlone is expanding in order to meet growing customer demand in Europe, the Middle East and Africa, and the Asia-Pacific region.
“Our enlarged operations will enhance our capabilities in leading technologies related to biopharmaceutical testing and speciality testing for biologics and small molecules”
The Athlone GMP (good manufacturing practices) lab provides fully integrated analytical services across all phases of pharmaceutical development and commercialisation, helping clients fulfil regulatory requirements for release testing and qualified person (QP) services for clinical and marketed pharmaceuticals, including small and large molecules, inhaled products, and cell and gene therapies.
A chemical connection
The current 4,460 sq. meter (48,000 sq. foot) operation will grow to 7,710 sq. meters (83,000 sq. feet) upon completion of the project, which is expected to be fully functional by mid-2022 and is projected to create 180 new jobs over the next three years.
It employs nearly 300 highly skilled scientists and project managers who support the demand for PPD’s services, which includes testing to support the development of novel and advanced pharmaceuticals and therapies.
“Our enlarged operations will enhance our capabilities in leading technologies related to biopharmaceutical testing and speciality testing for biologics and small molecules,” said Christopher Fikry, managing director of PPD Laboratories.
“This expansion will enable PPD to provide customers with additional services aimed at reducing time to market for new drug products in important areas such as cell and gene therapies. We are thankful our expansion has been welcomed and supported by the Irish Government and IDA Ireland, and we’re confident these new developments will benefit our customers.”
CEO of IDA Ireland Martin Shanahan added: “Today’s announcement by PPD demonstrates the company’s commitment to Ireland and indeed the Midlands Region where it has been in operation for more than 10 years.
“It will allow the company to avail itself of the rich talent pool that exists in the Midlands and will provide an economic and employment boost to the local and wider Midlands region. We wish PPD continued success.”
By John Kennedy (firstname.lastname@example.org)
Published: 28 April 2021